These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 14036621)

  • 21. Aggressive NK-cell leukaemia associated with reactive haemophagocytic syndrome.
    Choi YL; Park JH; Kim WS; Lee DY; Lee JH; Yang JM; Lee ES
    Clin Exp Dermatol; 2006 Jan; 31(1):83-5. PubMed ID: 16309492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth factor-independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate.
    Elmaagacli AH; Koldehoff M; Zakrzewski JL; Steckel NK; Ottinger H; Beelen DW
    Br J Haematol; 2007 Jan; 136(2):212-9. PubMed ID: 17156408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On the modification of indices of the natural resistance in patients with various forms of leukemia].
    KLIMOVA KN; IVANOVA NM
    Vopr Onkol; 1961; 7(2)():3-9. PubMed ID: 13756847
    [No Abstract]   [Full Text] [Related]  

  • 24. Biological models for leukaemia and lymphoma.
    Greaves MF
    IARC Sci Publ; 2004; (157):351-72. PubMed ID: 15055306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abrogation of adoptive immunity to a leukemic homograft by treatment of the donors with cortisone.
    GASIC G; HOECKER G; PIZARRO O; BAYDAK T
    Transplant Bull; 1957 Oct; 4(4):150-2. PubMed ID: 13507157
    [No Abstract]   [Full Text] [Related]  

  • 26. Aleukaemic leukaemia cutis as an initial manifestation of myeloid/NK cell precursor acute leukaemia.
    Dekio I; Anzai H; Ohyama M; Tanikawa A; Amagai M; Yokoyama K; Okamoto S; Tanaka M
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):453-6. PubMed ID: 16643148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute undifferentiated leukaemia in adult presenting as arthritis.
    Chauhan S; Telhan A; Agarwal V; Varma N
    Singapore Med J; 2006 Nov; 47(11):1004-5. PubMed ID: 17075674
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunotherapeutic peptide vaccination with leukemia-associated antigens.
    Rusakiewicz S; Molldrem JJ
    Curr Opin Immunol; 2006 Oct; 18(5):599-604. PubMed ID: 16870418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma.
    Farag SS; Caligiuri MA
    Adv Pharmacol; 2004; 51():295-318. PubMed ID: 15464915
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of antileukemic immunity mediated by dendritic cells derived from multidrug resistant leukemia K562/A02 cells and sensitive K562 cells.
    Zhang YM; Zhang LS; Zhang YF; Chai Y; Yi LC; Song FX
    Chin Med J (Engl); 2005 Apr; 118(7):595-7. PubMed ID: 15820092
    [No Abstract]   [Full Text] [Related]  

  • 31. Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation.
    Passweg JR; Koehl U; Uharek L; Meyer-Monard S; Tichelli A
    Best Pract Res Clin Haematol; 2006; 19(4):811-24. PubMed ID: 16997185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antileukemic activity of natural killer cells in allogeneic BMT.
    Bianchi E; Rogge L
    MedGenMed; 2003 Jul; 5(3):9. PubMed ID: 14600646
    [No Abstract]   [Full Text] [Related]  

  • 33. Introduction: The role of inflammation, autoimmune disease and infectious agents in development of leukaemia and lymphoma.
    Rosenquist R
    J Intern Med; 2008 Dec; 264(6):512-3. PubMed ID: 19017175
    [No Abstract]   [Full Text] [Related]  

  • 34. Growth factors and DLI in adult haploidentical transplant: a three-step pilot study towards patient and disease status adjusted management.
    Lewalle P; Delforge A; Aoun M; Crombez P; de Wilde V; Theunissen K; Lagneaux L; Nowak B; Misplon V; Bron D; Martiat P
    Blood Cells Mol Dis; 2004; 33(3):256-60. PubMed ID: 15528140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causes of childhood leukaemia and lymphoma.
    Lightfoot TJ; Roman E
    Toxicol Appl Pharmacol; 2004 Sep; 199(2):104-17. PubMed ID: 15313583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotype and natural killer cell sensitivity of a radiation-induced acute T-cell leukaemia (Roser leukaemia) in PVG rats.
    Nestvold J; Stokland A; Naper C; Rolstad B
    Scand J Immunol; 2004; 60(1-2):153-8. PubMed ID: 15238084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Leukemic dendritic cells].
    Gal'tseva IV; Pashin LE; Savchenko VG
    Ter Arkh; 2008; 80(7):84-8. PubMed ID: 18763607
    [No Abstract]   [Full Text] [Related]  

  • 38. Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers.
    Löfström B; Backlin C; Sundström C; Hellström-Lindberg E; Ekbom A; Lundberg IE
    Rheumatology (Oxford); 2009 Oct; 48(10):1222-6. PubMed ID: 19608725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status of gene expression profiling in the diagnosis and management of acute leukaemia.
    Bacher U; Kohlmann A; Haferlach T
    Br J Haematol; 2009 Jun; 145(5):555-68. PubMed ID: 19344393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy.
    Hassan HT
    Leuk Res; 2004 Jul; 28(7):667-71. PubMed ID: 15158086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.